NCT00837018
- Conditions
- Apnea, Behavior, Dyssomnias, +9 more
- Locations
-
- CHU, medecine du sport Grenoble, France
Clinical trial condition
Sleep Disorders, Intrinsic
Explore clinical trials studying Sleep Disorders, Intrinsic. Study availability and eligibility vary by location and protocol.
4,492 public trials
665 recruiting studies
Sleep Disorders, Intrinsic trial results
NCT00540254
- Conditions
- Behavioral Therapy Targeted to Sleep Problems, Chronic Disease, Chronic Fatigue Syndrome, +15 more
- Locations
-
- Duke University Medical Center - Insomnia and Sleep Disorders Lab Durham, North Carolina, United States
NCT01086800
- Conditions
- Apnea, Arterial Occlusive Diseases, Arteriosclerosis, +16 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
- Partners HealthCare Boston, Massachusetts, United States
- VA Boston Healthcare System Boston, Massachusetts, United States
- Case Western Reserve University Cleveland, Ohio, United States
NCT00912171
- Conditions
- Apnea, Dyssomnias, Nervous System Diseases, +12 more
- Locations
-
- Department if Pediatrics, Hospital S. Orsola-Malpighi , University of Bologna Bologna, Italy
Completed
Continuous Positive Airway Pressure (CPAP) Mode Impact on Clinical Blood Arterial Pressure
NCT01090297
- Conditions
- Apnea, Dyssomnias, Nervous System Diseases, +7 more
- Locations
-
- AGIR à Dom Meylan, France
Completed
A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)
NCT01055834
- Conditions
- Dyssomnias, Insomnia, Mental Disorders, +4 more
- Locations
-
- Sumida City, Tokyo, Japan
NCT01067235
- Conditions
- Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +9 more
- Locations
-
- Neurocenter (EOC) of Southern Switzerland Lugano, Switzerland
Completed
PAP Therapy Sleep Apnea and Exercise
NCT01786291
- Conditions
- Apnea, Dyssomnias, Nervous System Diseases, +7 more
- Locations
-
- University of Gaziantep, Faculty of Medicine, Dept. of Pulmonary Diseases Gaziantep, Turkey (Türkiye)
Completed
A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)
NCT00770510
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Toyohashi, Aichi-ken, Japan
- Akita, Japan
- Fukuoka, Japan
- Kitakyushu, Fukuoka, Japan
NCT00701038
- Conditions
- Apnea, Cardiovascular Diseases, Dyssomnias, +10 more
- Locations
-
Not specified